Effect of Electronic Activity Monitors and Pedometers on Health: Results from the TAME Health Pilot Randomized Pragmatic Trial.
Zakkoyya H LewisKenneth J OttenbacherSteve R FisherKristofer JenningsArleen F BrownMaria Chang SwartzEloisa MartinezElizabeth J LyonsPublished in: International journal of environmental research and public health (2020)
Background: Brief counseling and self-monitoring with a pedometer are common practice within primary care for physical activity promotion. It is unknown how high-tech electronic activity monitors compare to pedometers within this setting. This study aimed to investigate the outcomes, through effect size estimation, of an electronic activity monitor-based intervention to increase physical activity and decrease cardiovascular disease risk. Method: The pilot randomized controlled trial was pre-registered online at clinicaltrials.gov (NCT02554435). Forty overweight, sedentary participants 55-74 years of age were randomized to wear a pedometer or an electronic activity monitor for 12 weeks. Physical activity was measured objectively for 7 days at baseline and follow-up by a SenseWear monitor and cardiovascular disease risk was estimated by the Framingham risk calculator. Results: Effect sizes for behavioral and health outcomes ranged from small to medium. While these effect sizes were favorable to the intervention group for physical activity (PA) (d = 0.78) and general health (d = 0.39), they were not favorable for measures. Conclusion: The results of this pilot trial show promise for this low-intensity intervention strategy, but large-scale trials are needed to test its efficacy.
Keyphrases
- physical activity
- randomized controlled trial
- study protocol
- cardiovascular disease
- primary care
- healthcare
- public health
- phase iii
- health information
- body mass index
- open label
- double blind
- mental health
- clinical trial
- placebo controlled
- metabolic syndrome
- health promotion
- social media
- systematic review
- coronary artery disease
- machine learning
- cardiovascular events
- quality improvement
- human immunodeficiency virus
- gestational age
- antiretroviral therapy
- adipose tissue
- skeletal muscle